Your browser doesn't support javascript.
loading
Sarcoidosis following alemtuzumab treatment for multiple sclerosis.
Willis, Mark D; Hope-Gill, Ben; Flood-Page, Patrick; Joseph, Fady; Needham, Ed; Jones, Joanne; Coles, Alasdair; Robertson, Neil P.
Afiliación
  • Willis MD; Institute of Psychological Medicine and Clinical Neuroscience, Cardiff University and University Hospital of Wales, Cardiff, UK; Department of Neurology, University Hospital of Wales, Cardiff, UK.
  • Hope-Gill B; Department of Respiratory Medicine, University Hospital Llandough, Llandough, UK.
  • Flood-Page P; Department of Respiratory Medicine, Royal Gwent Hospital, Newport, UK.
  • Joseph F; Department of Neurology, Royal Gwent Hospital, Newport, UK.
  • Needham E; Department of Neurology, Addenbrooke's Hospital, Cambridge, UK.
  • Jones J; Department of Neurology, Addenbrooke's Hospital, Cambridge, UK.
  • Coles A; Department of Neurology, Addenbrooke's Hospital, Cambridge, UK.
  • Robertson NP; Institute of Psychological Medicine and Clinical Neuroscience, Cardiff University and University Hospital of Wales, Cardiff, UK; Department of Neurology, University Hospital of Wales, Cardiff, UK.
Mult Scler ; 24(13): 1779-1782, 2018 11.
Article en En | MEDLINE | ID: mdl-30307364

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Sarcoidosis / Enfermedades Autoinmunes / Alemtuzumab / Esclerosis Múltiple Tipo de estudio: Observational_studies Límite: Adult / Female / Humans / Male Idioma: En Revista: Mult Scler Asunto de la revista: NEUROLOGIA Año: 2018 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Sarcoidosis / Enfermedades Autoinmunes / Alemtuzumab / Esclerosis Múltiple Tipo de estudio: Observational_studies Límite: Adult / Female / Humans / Male Idioma: En Revista: Mult Scler Asunto de la revista: NEUROLOGIA Año: 2018 Tipo del documento: Article País de afiliación: Reino Unido